Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

被引:2
作者
Buse, Dawn C. [1 ]
Nahas, Stephanie J. [2 ]
Stewart, Walter F. [3 ]
Armand, Cynthia E. [1 ]
Reed, Michael L. [4 ]
Fanning, Kristina M. [5 ]
Adams, Aubrey Manack [6 ]
Lipton, Richard B. [1 ]
机构
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Medcurio, Oakland, CA USA
[4] Vedanta Res, Chapel Hill, NC USA
[5] MIST Res, Wilmington, NC USA
[6] AbbVie, 2525 Dupont Dr, Irvine, CA 92612 USA
关键词
absenteeism; presenteeism; headache; migraine; employment; disability; productivity; QUALITY-OF-LIFE; AMERICAN-MIGRAINE; EPISODIC MIGRAINE; WORK IMPACT; HEADACHE; DISABILITY; PREVALENCE; BURDEN; IMPAIRMENT; ALLODYNIA;
D O I
10.1097/JOM.0000000000002801
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: This study aimed to ascertain whether level of optimization of acute treatment of migraine is related to work productivity across the spectrum of migraine.Methods: Data were from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study, an internet-based longitudinal survey. Respondents with migraine who reported full-time employment and use of >= 1 acute prescription medication for migraine were included. We determined relationships among lost productive time (LPT; measured with the Migraine Disability Assessment Scale), acute treatment optimization (Migraine Treatment Optimization Questionnaire- ), and monthly headache days (MHDs). Results: There was a direct relationship between LPT and MHD category. Greater acute treatment optimization was associated with lower total LPT, less absenteeism, and less presenteeism within each MHD category. Conclusions: Optimizing acute treatment for migraine may reduce LPT in people with migraine and reduce indirect costs.
引用
收藏
页码:E261 / E268
页数:8
相关论文
共 50 条
  • [41] Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
    Buse, Dawn C.
    Manack, Aubrey N.
    Fanning, Kristina M.
    Serrano, Daniel
    Reed, Michael L.
    Turkel, Catherine C.
    Lipton, Richard B.
    HEADACHE, 2012, 52 (10): : 1456 - 1470
  • [42] A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability
    Lipton, Richard B.
    Adams, Aubrey Manack
    Buse, Dawn C.
    Fanning, Kristina M.
    Reed, Michael L.
    HEADACHE, 2016, 56 (08): : 1280 - 1289
  • [43] The acute treatment of episodic and chronic migraine in the USA
    Bigal, M. E.
    Borucho, S.
    Serrano, D.
    Lipton, R. B.
    CEPHALALGIA, 2009, 29 (08) : 891 - 897
  • [44] Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center
    Seng, Elizabeth K.
    Buse, Dawn C.
    Klepper, Jaclyn E.
    Mayson, Sarah J.
    Grinberg, Amy S.
    Grosberg, Brian M.
    Pavlovic, Jelena M.
    Robbins, Matthew S.
    Vollbracht, Sarah E.
    Lipton, Richard B.
    HEADACHE, 2017, 57 (04): : 593 - 604
  • [45] Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
    Bloudek, L. M.
    Stokes, M.
    Buse, D. C.
    Wilcox, T. K.
    Lipton, R. B.
    Goadsby, P. J.
    Varon, S. F.
    Blumenfeld, A. M.
    Katsarava, Z.
    Pascual, J.
    Lanteri-Minet, M.
    Cortelli, P.
    Martelletti, P.
    JOURNAL OF HEADACHE AND PAIN, 2012, 13 (05) : 361 - 378
  • [46] Migraine diagnosis and treatment: Results from the American Migraine Study II
    Lipton, RB
    Diamond, S
    Reed, M
    Diamond, ML
    Stewart, WF
    HEADACHE, 2001, 41 (07): : 638 - 645
  • [47] Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine
    Mangrum, Rikki
    Gerstein, Maya T.
    Hall III, Calvin J. J.
    Buse, Dawn C.
    Houts, Carrie R.
    McGinley, James S.
    McCarrier, Kelly P.
    Lipton, Richard B.
    Wirth, R. J.
    HEADACHE, 2023, 63 (07): : 953 - 964
  • [48] Nerivio® remote electrical neuromodulation for acute treatment of chronic migraine
    Nierenburg, Hida
    Stark-Inbar, Alit
    PAIN MANAGEMENT, 2021,
  • [49] Asthma Is a Risk Factor for New Onset Chronic Migraine: Results from the American Migraine Prevalence and Prevention Study
    Martin, Vincent T.
    Fanning, Kristina M.
    Serrano, Daniel
    Buse, Dawn C.
    Reed, Michael L.
    Lipton, Richard B.
    HEADACHE, 2016, 56 (01): : 118 - 131
  • [50] Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study
    Awaki, Etsuko
    Takeshima, Takao
    Matsumori, Yasuhiko
    Hirata, Koichi
    Miyazaki, Naoki
    Takemura, Ryo
    Osaga, Satoshi
    Tanizawa, Yoshinori
    Komori, Mika
    NEUROLOGY AND THERAPY, 2024, 13 (01) : 165 - 182